Transformational Opportunities: UBS Suggests 2 Longevity Stocks to Buy as the $8T Aging Boom Accelerates
Yahoo Finance·2026-03-21 11:05

Two fields in particular draw attention when we look at Abbott. The company’s FreeStyle Libre product is a leader in the continuous glucose monitoring (CGM) market, a vital technology in controlling and managing diabetes. Abbott’s product boasts that it is the leading CGM brand in the US. Abbott’s cardiovascular products include devices to manage such conditions as heart failure, irregular heartbeat, and mitral regurgitation.The first company we’ll look at, Abbott Laboratories, was founded in 1888 – and has ...

Transformational Opportunities: UBS Suggests 2 Longevity Stocks to Buy as the $8T Aging Boom Accelerates - Reportify